Literature DB >> 35157219

T cell responses to SARS-CoV-2 in humans and animals.

Sameer-Ul-Salam Mattoo1, Jinjong Myoung2.   

Abstract

SARS-CoV-2, the causative agent of COVID-19, first emerged in 2019. Antibody responses against SARS-CoV-2 have been given a lot of attention. However, the armamentarium of humoral and T cells may have differing roles in different viral infections. Though the exact role of T cells in COVID-19 remains to be elucidated, prior experience with human coronavirus has revealed an essential role of T cells in the outcomes of viral infections. Moreover, an increasing body of evidence suggests that T cells might be effective against SARS-CoV-2. This review summarizes the role of T cells in mouse CoV, human pathogenic respiratory CoV in general and SARS-CoV-2 in specific.
© 2022. The Microbiological Society of Korea.

Entities:  

Keywords:  SARS-CoV-2; T cell; coronavirus; immune response

Mesh：

Substances：

Year:  2022        PMID： 35157219      PMCID： PMC8852923          DOI： 10.1007/s12275-022-1624-z

Source DB:  PubMed          Journal:  J Microbiol        ISSN： 1225-8873            Impact factor:   2.902


  117 in total

1.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

Authors:  Nina Le Bert; Anthony T Tan; Kamini Kunasegaran; Christine Y L Tham; Morteza Hafezi; Adeline Chia; Melissa Hui Yen Chng; Meiyin Lin; Nicole Tan; Martin Linster; Wan Ni Chia; Mark I-Cheng Chen; Lin-Fa Wang; Eng Eong Ooi; Shirin Kalimuddin; Paul Anantharajah Tambyah; Jenny Guek-Hong Low; Yee-Joo Tan; Antonio Bertoletti
Journal:  Nature       Date:  2020-07-15       Impact factor: 49.962

2.  T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice.

Authors:  Jincun Zhao; Jingxian Zhao; Stanley Perlman
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

3.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients.

Authors:  Ditte Stampe Hersby; Tripti Tamhane; Sunil Kumar Saini; Helle Rus Povlsen; Susana Patricia Amaya Hernandez; Morten Nielsen; Anne Ortved Gang; Sine Reker Hadrup
Journal:  Sci Immunol       Date:  2021-04-14

5.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

6.  Persistent cellular immunity to SARS-CoV-2 infection.

Authors:  Gaëlle Breton; Pilar Mendoza; Thomas Hägglöf; Thiago Y Oliveira; Dennis Schaefer-Babajew; Christian Gaebler; Martina Turroja; Arlene Hurley; Marina Caskey; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2021-04-05       Impact factor: 14.307

7.  Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.

Authors:  Mariana O Diniz; Nathalie M Schmidt; Oliver E Amin; Aneesh Chandran; Emily Shaw; Leo Swadling; Corinna Pade; Joseph M Gibbons; Nina Le Bert; Anthony T Tan; Anna Jeffery-Smith; Cedric C S Tan; Christine Y L Tham; Stephanie Kucykowicz; Gloryanne Aidoo-Micah; Joshua Rosenheim; Jessica Davies; Marina Johnson; Melanie P Jensen; George Joy; Laura E McCoy; Ana M Valdes; Benjamin M Chain; David Goldblatt; Daniel M Altmann; Rosemary J Boyton; Charlotte Manisty; Thomas A Treibel; James C Moon; Lucy van Dorp; Francois Balloux; Áine McKnight; Mahdad Noursadeghi; Antonio Bertoletti; Mala K Maini
Journal:  Nature       Date:  2021-11-10       Impact factor: 69.504

Review 8.  Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact.

Authors:  Sifan Zhang; Becca Asquith; Richard Szydlo; John S Tregoning; Katrina M Pollock
Journal:  Immunother Adv       Date:  2021-07-02

9.  Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015.

Authors:  Wen Da Guan; Chris Ka Pun Mok; Zi Lin Chen; Li Qiang Feng; Zheng Tu Li; Ji Cheng Huang; Chang Wen Ke; Xilong Deng; Yun Ling; Shi Guan Wu; Xue Feng Niu; Ranawaka A Perera; Yuan Da Xu; Jincun Zhao; Lin Qi Zhang; Yi Min Li; Rong Chang Chen; Malik Peiris; Ling Chen; Nan Shan Zhong
Journal:  Emerg Infect Dis       Date:  2015-12       Impact factor: 6.883
View more
  3 in total

1.  Two years of COVID-19 pandemic: where are we now?

Authors:  Jinjong Myoung
Journal:  J Microbiol       Date:  2022-03       Impact factor: 3.422

2.  Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.

Authors:  Irina Isakova-Sivak; Ekaterina Stepanova; Victoria Matyushenko; Sergei Niskanen; Daria Mezhenskaya; Ekaterina Bazhenova; Elena Krutikova; Tatiana Kotomina; Polina Prokopenko; Bogdan Neterebskii; Aleksandr Doronin; Elena Vinogradova; Kirill Yakovlev; Konstantin Sivak; Larisa Rudenko
Journal:  Vaccines (Basel)       Date:  2022-07-18

Review 3.  Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin.

Authors:  Sameer-Ul-Salam Mattoo; Seong-Jun Kim; Dae-Gyun Ahn; Jinjong Myoung
Journal:  Viruses       Date:  2022-03-04       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.